Navigation Links
New therapy with stem cells to treat Crohn's disease
Date:2/19/2009

disease presents several treatment options. Firstly, doctors choose to use corticosteroids and immunosuppressant and biological drugs to control the inflammatory process and prevent complications of the disease such as stenosis (narrowing of the intestinal lumen) or fistulas (openings from the intestinal lumen to other organs, such as the intestine, bladder, vagina, or skin). However, over the course of the disease, as much as 70% of severe patients require surgery to remove segments affected by the disease, due to failure of the pharmacologic approach. The surgery is occasionally very aggressive for the patient, as it is sometimes necessary to remove the entire colon or large sections of the small intestine, thereby considerably affecting the absorption of food by the intestine, with a resulting deterioration in quality of life and body image (colostomy bag). For this reason, new treatments are being developed for patients in whom this solution has not been an option to date.

Autologous Stem-Cell Transplant: Phases of the Procedure.

When the case is detected (that does not respond to drugs or surgery), the patient undergoes an autologous stem-cell transplant, which is a bone-morrow transplant in which the immune system is reset to prevent it from attacking the intestinal flora. The process lasts approximately 2 months and consists of 6 phases:

  1. Initial Chemotherapy (Cyclophosphamide + G-CSF). In this initial phase, leukopenia or reduction of the number of leukocytes (immune-system cells) in the blood is induced in the patient.

  2. Migration of Stem-Cells to the Blood. Following the previous immunosuppression, the organism reacts by releasing stem cells from the bone marrow into the blood; these are the cells which will later be used for the transplant.

  3. Collection of Stem Cells by means of Apheresis. Apheresis is a technique that separates components of the blood. Here, the stem cells that previously migrated
    '/>"/>

Contact: Maria Trenzado
trenzado@clinic.ub.es
34-932-275-700
IDIBAPS - Institut d'Investigacions Biomdiques August Pi i Sunyer
Source:Eurekalert  

Page: 1 2 3 4 5

Related medicine news :

1. A potential molecular target for biotherapy esophageal squamous cell carcinomas
2. What is the most effective therapy for low-dose aspirin induced peptic ulcer?
3. Varian Medical Systems Has Received CE Mark for Proton Therapy System
4. Dr. Larry Kaskel, Medical Director of the Heart Attack Prevention Center, to Speak March 4th at CardioCareLive about FirstLine Therapy
5. Apple's iPod Touch Joins the iPhone as a Stuttering Therapy Tool At Hollins Communications Research Institute
6. Supplement of probiotics provides a new therapy for ulcerative colitis
7. An adjuvant chemotherapeutic agent in gastric cancer therapy
8. MU researcher demonstrates non-traditional therapy is effective as pain management
9. Public Cancer Center Becomes First in South-East Asia to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
10. Lung Cancer Microscopic Appearance Affects Response to Chemotherapy
11. Gene Therapy Holds Promise for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New therapy with stem cells to treat Crohn's disease
(Date:8/1/2014)... Blindness is a reversible ailment these days . ... despite well-meaning efforts, still have a long way to go ... blindness that does not involve any kind of health risk ... takes the “slack” from the mainstream by providing a cure ... , Alternative health specialist Kevin Richardson actually has the ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 AAGL, ... gynecologic endoscopic surgery, is pleased to announce a ... the United States and Europe, which strongly recommends ... to surgeons an endoscopic dry lab for training ... their endoscopic surgery skills. , Endoscopy is the ...
(Date:8/1/2014)... Surftech athletes Jack Bark and Carter Graves won ... past weekend in Hawaii in commanding fashion shattering world ... were all on stock Surftech Bark Commanders. The event ... this year were treated to 6-10 foot seas and ... as well as very fast. , The win ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 iFitDress.com, a ... unveiled its new collection of 2014 silver bridesmaid ... are manufactured according to the latest fashion trends. What’s ... 15 to 55 percent off. , iFitDress.com is ... it deals in not only silver bridesmaid gowns, but ...
(Date:7/31/2014)... over the age of 65 face numerous barriers to ... against poverty and higher rates of asthma with worse ... of Annals of Allergy, Asthma and Immunology , ... Asthma and Immunology (ACAAI), outlines the challenges faced by ... to improve their care. , "Allergists want ...
Breaking Medicine News(10 mins):Health News:The Miracle Cure Review | The Unbeatable Secret to Reversing Any Vision Problem – Vinamy.com 2Health News:AAGL Announces It Has Joined With Other Medical Societies to Encourage Hospitals Teaching Endoscopic Surgery to Establish Simulator Labs for Training 2Health News:Surftech Bark Commander Sweeps Molokai2Oahu Stock Paddleboard Division 2Health News:iFitDress.com: Beautiful Silver Bridesmaid Dresses at Promotional Prices 2Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3
... , WASHINGTON, Sept. 11 The ... and Economic Studies: , , WHO : ... Johns Hopkins University Bloomberg School of Public Health, Drexel University School ... , , WHAT : The Joint Center,s ...
... disease progression , FRIDAY, Sept. 11 (HealthDay News) -- Two ... body,s ability to repair itself when afflicted with multiple sclerosis, ... , "Most MS genetic studies have looked at disease susceptibility ... not," study author Allan Bieber, a Mayo Clinic neuroscientist, said ...
... legs as they get older? As we age it becomes harder ... and increases the likelihood of falls and fractures. New research is ... A team of Nottingham researchers has already shown that when ... young. Now they,ve found that the suppression of muscle breakdown, which ...
... oxygen-carrying component of hemoglobin, the protein that makes blood ... and energy metabolism within the cell. Heme levels are ... prevents cell growth and division; excessive amounts of heme ... Pennsylvania School of Medicine have discovered a molecular circuit ...
... , , PHOENIX, Sept. 11 ... Health Plan Arizona President Tom Lescault co-hosts "Senior Focus" every other ... producer of the "Valley Views" show, Lescault interviews local experts on ... ",Senior Focus, is about seniors, for seniors and reflective of seniors, ...
... , , , ... and Union Activism , , SILVER ... convention starting Sept. 14, AFL-CIO will honor the work of UAN,s ... work helped make workers, voices heard. , , ...
Cached Medicine News:Health News:Joint Center to Unveil Health Reform Study Providing Answers: What Is the Cost of Not Addressing Racial Health Disparities? 2Health News:Muscle: 'Hard to build, easy to lose' as you age 2Health News:Inner workings of molecular thermostat point to pathways to fight diabetes, obesity 2Health News:Inner workings of molecular thermostat point to pathways to fight diabetes, obesity 3Health News:SCAN Health Plan CEO Tom Lescault Hosts Biweekly 'Senior Focus' Show on KOY-1230AM, Seeks Input from Area Seniors 2Health News:UAN Nurse Among Political Activists To Be Honored by AFL-CIO 2
(Date:7/31/2014)... WASHINGTON , July 31, 2014  According to ... Medicaid Services, the 2015 average monthly Medicare Part D ... figure far lower than was originally projected, the Pharmaceutical ... Part D program continues to be a bright spot ... competing choices in each region and using cutting edge, ...
(Date:7/31/2014)... 31, 2014  ResMed Inc. (NYSE: RMD ) ... fiscal year ended June 30, 2014.  Revenue for the quarter ... 30, 2013 (a 1 percent decrease on a constant currency ... percent compared to the quarter ended June 30, 2013. Diluted ... of 22 percent compared to the quarter ended June 30, ...
(Date:7/31/2014)... , July 31, 2014  Cepheid (NASDAQ: CPHD ... the following conferences, and invited investors to participate via webcast. ... New York, NY Wednesday, August 13, ... Health Care Conference, New York, NY ... Accessing Live Webcasts To access the live webcasts ...
Breaking Medicine Technology:RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 2RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 3RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 4RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 5RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 6RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 7RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 8RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 9RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 10RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 11RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 12RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 13Cepheid to Webcast Upcoming Financial Presentations 2
... March 18th publication in prominent peer-reviewed journal ... drug-resistant staph infection, EVANSTON, Ill., March ... aureus (MRSA) using a,rapid molecular diagnostic test ... to research published in the Annals of ...
... 2b in Second Quarter of 2008 - ... Tomorrow at 8:00 a.m. Eastern Time -, SAN ... ) today announced positive preliminary results from its,ongoing Phase ... transcriptase inhibitor (NNRTI), in,patients with human immunodeficiency virus (HIV)., ...
Cached Medicine Technology:Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention 2Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention 3Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 2Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 3Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 4
Icefire has ice crystals on the top of a cool blue iris....
This design features a solid red iris....
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Medicine Products: